rs17686866

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000359162.6(ESRRG):​c.-105-72250G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.157 in 152,092 control chromosomes in the GnomAD database, including 2,463 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.16 ( 2463 hom., cov: 32)

Consequence

ESRRG
ENST00000359162.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.32

Publications

8 publications found
Variant links:
Genes affected
ESRRG (HGNC:3474): (estrogen related receptor gamma) This gene encodes a member of the estrogen receptor-related receptor (ESRR) family, which belongs to the nuclear hormone receptor superfamily. All members of the ESRR family share an almost identical DNA binding domain, which is composed of two C4-type zinc finger motifs. The ESRR members are orphan nuclear receptors; they bind to the estrogen response element and steroidogenic factor 1 response element, and activate genes controlled by both response elements in the absence of any ligands. The ESRR family is closely related to the estrogen receptor (ER) family. They share target genes, co-regulators and promoters, and by targeting the same set of genes, the ESRRs seem to interfere with the ER-mediated estrogen response in various ways. It has been reported that the family member encoded by this gene functions as a transcriptional activator of DNA cytosine-5-methyltransferases 1 (Dnmt1) expression by direct binding to its response elements in the DNMT1 promoters, modulates cell proliferation and estrogen signaling in breast cancer, and negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation and bone formation. Multiple alternatively spliced transcript variants have been identified, which mainly differ at the 5' end and some of which encode protein isoforms differing in the N-terminal region. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.211 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000359162.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ESRRG
NM_001134285.3
c.-229-52238G>T
intron
N/ANP_001127757.1
ESRRG
NM_001243509.2
c.-577-11199G>T
intron
N/ANP_001230438.1
ESRRG
NM_001243510.3
c.-223-72250G>T
intron
N/ANP_001230439.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ESRRG
ENST00000359162.6
TSL:1
c.-105-72250G>T
intron
N/AENSP00000352077.2
ESRRG
ENST00000366940.6
TSL:1
c.-229-52238G>T
intron
N/AENSP00000355907.2
ESRRG
ENST00000493603.5
TSL:1
c.-223-72250G>T
intron
N/AENSP00000419594.1

Frequencies

GnomAD3 genomes
AF:
0.158
AC:
23953
AN:
151974
Hom.:
2462
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0351
Gnomad AMI
AF:
0.135
Gnomad AMR
AF:
0.216
Gnomad ASJ
AF:
0.147
Gnomad EAS
AF:
0.205
Gnomad SAS
AF:
0.0741
Gnomad FIN
AF:
0.320
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.197
Gnomad OTH
AF:
0.150
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.157
AC:
23953
AN:
152092
Hom.:
2463
Cov.:
32
AF XY:
0.164
AC XY:
12200
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.0350
AC:
1452
AN:
41518
American (AMR)
AF:
0.217
AC:
3309
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.147
AC:
511
AN:
3468
East Asian (EAS)
AF:
0.205
AC:
1062
AN:
5182
South Asian (SAS)
AF:
0.0742
AC:
358
AN:
4826
European-Finnish (FIN)
AF:
0.320
AC:
3375
AN:
10532
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.197
AC:
13418
AN:
67986
Other (OTH)
AF:
0.149
AC:
313
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
986
1972
2958
3944
4930
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
252
504
756
1008
1260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.186
Hom.:
444
Bravo
AF:
0.149
Asia WGS
AF:
0.115
AC:
397
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.19
DANN
Benign
0.42
PhyloP100
-1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17686866; hg19: chr1-217185265; API